title: The use of alternate-day lovastatin in hypercholesterolemic men.
abstract: OBJECTIVE
  To quantitate the therapeutic effects of alternate-day lovastatin on serum lipoprotein values in a small group of men with primary hypercholesterolemia.
  
  
  METHODS
  Retrospective review of medical, pharmacy, and laboratory records. A paired Student's t-test was performed on absolute changes in lipoprotein values with an a priori p value less than or equal to 0.05 being statistically significant.
  
  
  METHODS
  A lipid clinic within a tertiary care Department of Veterans Affairs Medical Center.
  
  
  METHODS
  Twenty men (mean age 62.5 +/- 8.3 y) with mean +/- SD baseline low-density lipoprotein cholesterol (LDL-C) concentration of 161.3 +/- 21.9 mg/dL and triglyceride concentrations below 400 mg/dL.
  
  
  METHODS
  All patients had been prescribed lovastatin 20 mg every other day.
  
  
  METHODS
  The mean absolute and percent changes in lipoprotein values from baseline for patients receiving lovastatin 20 mg every other day and the percentage of patients attaining a target mean LDL-C concentration as defined by the National Cholesterol Education Panel Adult Treatment Panel II guidelines.
  
  
  RESULTS
  Mean +/- SD total cholesterol and LDL-C were significantly reduced by 32.4 +/- 17.8 (14.0% +/- 7.8%) and 34.1 +/- 14.6 mg/dL (21.5% +/- 9.7%), respectively. No significant changes were seen in high- density lipoprotein cholesterol or triglycerides. Four of 20 patients (20%) attained a goal LDL-C concentration.
  
  
  CONCLUSIONS
  Lovastatin 20 mg every other day may effectively lower LDL-C in some elderly men, and target LDL-C concentrations may be obtained in some patients.
authors.affiliation: Pharmacy Service, Department of Veterans Affairs Medical Center, Oklahoma City, OK, USA.
authors.forename: V C
authors.initials: VC
authors.lastname: Dennis
authors.forename: M L
authors.initials: ML
authors.lastname: Britton
authors.forename: S M
authors.initials: SM
authors.lastname: Sirmans
authors.forename: N A
authors.initials: NA
authors.lastname: Letassy
authors.forename: D A
authors.initials: DA
authors.lastname: Freeman
mesh_terms: D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004334:Drug Administration Schedule; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D008148:Lovastatin / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
chemical_list: D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D014280:Triglycerides; D008148:Lovastatin